Why did Acad drop so much?
Why did Acad drop so much? ACAD stock has had a volatile ride the past few months. However, over the recent weeks, the stock has plummeted to levels of $27 currently. The recent drop can be attributed to the U.S. FDA finding deficiencies in its application for its psychosis drug - Nuplazid. Is Acad a good buy? We believe that ACADIA Pharmaceuticals stock (NASDAQ NDAQ +0.6% : ACAD), a biopharmaceutical company focused on neuroscience drugs, is a good buying opportunity at the present time. However, over the recent weeks, the stock has plummeted to levels of $27 currently. What is...